piperidin-2-yl-acetic acid methyl ester hydrochloride | 24153-01-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: piperidin-2-yl-acetic acid methyl ester hydrochloride
• 英文别名: 2-carbomethoxymethylpiperidine hydrochloride；methyl 2-piperidylacetate hydrochloride；[2]piperidyl-acetic acid methyl ester; hydrochloride；[2]Piperidyl-essigsaeure-methylester; Hydrochlorid；2-(piperidinyl-2-yl)acetic acid methyl ester hydrochloride；piperidin-2-ylacetic acid methyl ester hydrochloride；Methyl 2-(piperidin-2-yl)acetate hydrochloride；methyl 2-piperidin-2-ylacetate;hydrochloride
• CAS: 24153-01-3
• 化学式: C₈H₁₅NO₂*ClH
• 分子量: 193.674
• InChiKey: KGLWWMPBPHRIHK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.11
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  piperidin-2-yl-acetic acid methyl ester hydrochloride 在 4-二甲氨基吡啶 、 Burkholderia cepacia PS-C II lipase 、 三乙胺 作用下， 以 氯仿 、 异丙醚 、 正丁醇 为溶剂， 反应 192.0h， 生成 N-Boc-2-哌啶乙酸甲酯
  参考文献：
  名称：

  Chemoenzymatic approach to enantiopure piperidine-based β-amino esters in organic solvents

  摘要：

  This research concentrates on the enantioselectivities of lipase-catalysed reactions with methyl esters of 2-piperidylacetic acid and 3-piperidinecarboxylic acid derivatives. N-Acetylated 2-piperidylacetic acid methyl ester displayed good enantioselectivity (E = 66) in a 1:1 mixture of diisopropyl ether and butyl butanoate in the presence of lipase PS-C IT from Burkholderia cepacia. The reaction is known as interesterification with butyl butanoate rather than alcoholysis with the butanol, because butyl butanoate has to be first hydrolysed or go through alcoholysis with MeOH in order to release butanol. Other N-protective groups (Boc, Ns, Fmoc and Bzn) gave excellent en anti oselectivity (E > 200) under the same conditions, and a gram-scale resolution was performed with N-Boc-2-piperidylacetic acid methyl ester. Reaction with a 3-piperidylcarboxylic acid derivative took place with disappointingly low enantioselectivity (E = 4), with Candida antarctica lipase B being the best of the lipases screened. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2007.01.027
• 作为产物：
  描述：

  2-吡啶基乙酸 在 platinum(IV) oxide 盐酸 、 氯化亚砜 、 氢气 作用下， 20.0 ℃ 、500.0 kPa 条件下， 反应 53.0h， 生成 piperidin-2-yl-acetic acid methyl ester hydrochloride
  参考文献：
  名称：

  Chemoenzymatic approach to enantiopure piperidine-based β-amino esters in organic solvents

  摘要：

  This research concentrates on the enantioselectivities of lipase-catalysed reactions with methyl esters of 2-piperidylacetic acid and 3-piperidinecarboxylic acid derivatives. N-Acetylated 2-piperidylacetic acid methyl ester displayed good enantioselectivity (E = 66) in a 1:1 mixture of diisopropyl ether and butyl butanoate in the presence of lipase PS-C IT from Burkholderia cepacia. The reaction is known as interesterification with butyl butanoate rather than alcoholysis with the butanol, because butyl butanoate has to be first hydrolysed or go through alcoholysis with MeOH in order to release butanol. Other N-protective groups (Boc, Ns, Fmoc and Bzn) gave excellent en anti oselectivity (E > 200) under the same conditions, and a gram-scale resolution was performed with N-Boc-2-piperidylacetic acid methyl ester. Reaction with a 3-piperidylcarboxylic acid derivative took place with disappointingly low enantioselectivity (E = 4), with Candida antarctica lipase B being the best of the lipases screened. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2007.01.027

文献信息

• Beta-Amino-Acid derivatives as inhibitors of matrix metalloproteases and TNF-Alpha
  申请人：——

  公开号：US20020013341A1

  公开（公告）日：2002-01-31

  The present application describes novel &bgr;-amino acid derivatives of formula I: 1 or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, U a , X a , Y a , Z a , R 1 , R 2 , R 3 , R 4 , and R 4a are defined in the present specification, which are useful as metalloprotease and/or as TNF-&agr; inhibitors.

  本申请描述了式I的新型β-氨基酸衍生物： 1 或其药用可接受的盐或前药形式，其中A、X、Z、U a 、X a 、Y a 、Z a 、R 1 、R 2 、R 3 、R 4 和R 4a 在本规范中有定义，这些衍生物可用作金属蛋白酶和/或TNF-α抑制剂。
• Substituted Sulfonamide Compounds
  申请人：MERLA Beatrix

  公开号：US20080312231A1

  公开（公告）日：2008-12-18

  Substituted sulfonamide compounds corresponding to formula I pharmaceutical compositions comprising them, a process for preparing them, and the use of such compounds to treat or inhibit pain and other disorders or disease states.

  将与式I相对应的磺胺化合物替代物 包括它们的药物组合物，制备它们的方法，以及利用这些化合物来治疗或抑制疼痛和其他疾病或疾病状态。
• Substituted Spiroamine Compounds
  申请人：REICH Melanie

  公开号：US20100113417A1

  公开（公告）日：2010-05-06

  Substituted spiroamine compounds corresponding to the formula (I) In which m, n, o, p, Q, r, s, t, R 1 , R 2 , R 3 , R 4a , R 4b , R 5a , R 5b , R 6a , R 6b , R 7 , R 8 , R 9 , R 10 and R 11 have defined meanings; a process for the preparation of such compounds, pharmaceutical compositions containing such compounds and the use of substituted spiroamines for the treatment or inhibition of pain and/or other conditions mediated by the bradykinin 1 receptor.

  将符合以下公式（I）的取代螺胺化合物 其中m、n、o、p、Q、r、s、t、R1、R2、R3、R4a、R4b、R5a、R5b、R6a、R6b、R7、R8、R9、R10和R11具有定义的含义；一种制备这种化合物的方法，含有这种化合物的药物组合物以及利用取代螺胺对布雷金肽1受体介导的疼痛和/或其他病症进行治疗或抑制。
• Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
  申请人：——

  公开号：US20040072802A1

  公开（公告）日：2004-04-15

  The present application describes novel &bgr;-amino acid derivatives of formula I: 1 or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, U a , X a , Y a , Z a , R 1 , R 2 , R 3 , R 4 , and R 4a are defined in the present specification, which are useful as metalloprotease and/or as TNF-&agr; inhibitors.

  本申请描述了式I的新颖β-氨基酸衍生物：1或其药用可接受的盐或前药形式，其中A、X、Z、Ua、Xa、Ya、Za、R1、R2、R3、R4和R4a在本规范中有定义，这些衍生物可用作金属蛋白酶和/或TNF-α抑制剂。
• [EN] SUBSTITUTED SULFONAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS SUBSTITUÉS DE SULFONAMIDE
  申请人：GRUENENTHAL GMBH

  公开号：WO2009124746A1

  公开（公告）日：2009-10-15

  The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

  这项发明涉及替代磺胺基衍生物，其制备方法，含有这些化合物的药物以及利用替代磺胺基衍生物制备药物。